All news

VERTEX PHARMACEUTICALS INC / MA Initial Statement of Beneficial Ownership

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

This article details the initial statement of beneficial ownership (Form 3) filed by Daniel J. Brennan for VERTEX PHARMACEUTICALS INC / MA (VRTX). The filing indicates Brennan's relationship to the issuer as a Director, with the event requiring the statement dated October 20, 2026. According to the document, no securities are beneficially owned by Brennan at this initial filing.

Read original source

VRTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.